LONDON CLINICAL AND LEGAL LIMITEDActive

Company number 08821264Private limited companyIncorporated 2013

Key figures

£444,439-9.8%
Net assets 2024/25
+11.1%
Average annual growth 2020/21–2024/25
0200 k400 k600 k2020/212021/222022/232023/242024/25

Like most small UK companies, LONDON CLINICAL AND LEGAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand144,71760,28359,005122,745103,293
Total assets394,744392,440465,933549,126535,454
Total liabilities——68,74159,96691,967
Net assets / total equity291,789333,816404,634492,463444,439
Average number of employees00110

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: LONDON CLINICAL AND LEGAL LIMITED

Company

LONDON CLINICAL AND LEGAL LIMITED is a private limited company registered with Companies House under company number 08821264. It was incorporated on 19 Dec 2013. Its status is active. The registered office is in Halesowen (B62). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Mar 2025); the company files small company accounts (filleted). Net assets were £444,439, down 9.8% on the previous year. Cash at bank and in hand was £103,293. Total assets were £535,454 and total liabilities £91,967. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Dec 2026. The next confirmation statement is due by 2 Jan 2027.